Across TCGA pan-cancer cohorts, EIF4A1P13 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of EIF4A1P13’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where EIF4A1P13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EIF4A1P13 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

LUAD, KIRP, and PAAD are the cancer types where EIF4A1P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EIF4A1P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	All	+0.204	.012	4	view →
KIRP	All	III,IV	+0.115	.021	4	view →
PAAD	Female	All	−0.385	.045	2	view →
COAD	All	All	+0.109	.019	2	view →
HNSC	Female	IV	+0.181	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: EIF4A1P13 RNA expression & survival · all EIF4A1P13 data types